Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07460882

The Impact of Low Sodium Salt Substitute Use on Serum Potassium Levels Among Patients With Hypertension

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
607 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this pre-post study is to assess the risk of hyperkalemia in adults with hypertension on medication in Bangladesh. The main questions it aims to answer are: Is the risk of hyperkalemia after the initiation of Low Sodium Salt Substitute (LSSS) in people on antihypertensive medication (especially RASi) large enough to be concerned about its broad use in this population? Does initiation of LSSS correct hypokalemia in people on antihypertensive medication (especially RASi) with low serum potassium levels? Participants will be asked to reduce overall salt intake and to use LSSS on every occasion where regular salt would normally be used, including as cooking salt.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow-sodium salt substituteThe low sodium salt substitute contains 25% potassium chloride (KCl range; 20%-35%)

Timeline

Start date
2026-05-01
Primary completion
2027-03-31
Completion
2027-09-30
First posted
2026-03-10
Last updated
2026-04-13

Source: ClinicalTrials.gov record NCT07460882. Inclusion in this directory is not an endorsement.